Corline Biomedical AB (OSTO:CLBIO) Short Interest


OSTO:CLBIO Corline Biomedical AB OSTO:CLBIO
43 GF Score
Price kr17.75
GF Value kr4.95
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Corline Biomedical AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

OSTO:CLBIO vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Corline Biomedical AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Corline Biomedical AB Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Corline Biomedical AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Corline Biomedical AB's Short Interest falls into.


OSTO:CLBIO
43GF Score
Corline Biomedical AB OSTO:CLBIO
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Corline Biomedical AB (OSTO:CLBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Corline Biomedical AB stock appears to be overvalued. The current stock price of kr17.75 is trading 258.6% above its estimated GF Value™ of kr4.95. GuruFocus considers Corline Biomedical AB to be Significantly Overvalued.

Key valuation signals for OSTO:CLBIO:

  • Short Interest:
  • GF Value™: kr4.95 vs. price of kr17.75 (258.6% above fair value)
  • GF Score™: 43/100 with 3 warning signs

No single metric tells the full story. See the OSTO:CLBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Corline Biomedical AB Business Description

Address Lefflersgatan 5, Uppsala, SWE, 754 50
Corline Biomedical AB offers customers in the medical technology industry and regenerative medicine as well as transplant clinics products to manage immune thrombosis. The company offers a proprietary surface treatment technology, Corline Heparin Surface (CHS), which can be used in combination with all commonly used implant materials such as polymers (plastics) and various metals, but also for equipment where blood circulation occurs outside the body.
43GF Score

Get the complete analysis for OSTO:CLBIO

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr17.75
Price
kr4.95
GF Value